Drug Name: | 4-AcO-MET |
Cas Number: | 1445751-40-5 |
Pubchem: | 71308138 |
Chemspiderid: | 26633897 |
Unii: | PCJ17NV1P0 |
Synonyms: | 4-Acetoxy-MET; Metacetin; 4-Acetoxy-N-methyl-N-ethyltryptamine |
Iupac Name: | [3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-yl] acetate |
C: | 15 |
H: | 20 |
N: | 2 |
O: | 2 |
Smiles: | CCN(C)CCc1c[nH]c2c1c(ccc2)OC(=O)C |
Stdinchi: | 1S/C15H20N2O2/c1-4-17(3)9-8-12-10-16-13-6-5-7-14(15(12)13)19-11(2)18/h5-7,10,16H,4,8-9H2,1-3H3 |
Stdinchikey: | OMDKHOOGGJRLLX-UHFFFAOYSA-N |
4-acetoxy-MET (4-acetoxy-N-methyl-N-ethyltryptamine), also known as 4-AcO-MET or metacetin, is a hallucinogenic tryptamine. It is the acetate ester of 4-HO-MET, and a homologue of 4-AcO-DMT. It is a novel compound with very little history of human use.[1] It is sometimes sold as a research chemical by online retailers.
Due to its similarity to the psilocin prodrug 4-AcO-DMT, which is deacetylated to form psilocin in vivo,[2] [3] it is expected that 4-AcO-MET is also quickly hydrolyzed into 4-HO-MET by serum esterases, but human studies concerning the metabolic fate of this drug are lacking.
In the United States, 4-Acetoxy-MET is not scheduled. It may be considered an analogue of psilocin, a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical purposes could be considered a crime under the Federal Analogue Act.[4]
In Switzerland, 4-Acetoxy-MET is a controlled substance under Verzeichnis E.[5]
In the United Kingdom, 4-Acetoxy-MET is a Class A drug in the UK because it is an ester of the drug 4-HO-MET, which is a Class A drug under the tryptamine catch-all clause.[6]